The U.S. Food and Drug Administration permitted marketing of two devices that provide real-time location of parathyroid tissue during surgical procedures such as thyroidectomy (surgery to remove all or part of the thyroid) and parathyroidectomy (surgery to remove one or more parathyroid glands).

Alkermes plc (Nasdaq: ALKS) today announced that the Psychopharmacologic Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, appointed by the U.S. Food and Drug Administration (FDA), met to review the company's New Drug Application (NDA) for ALKS 5461.

Partner Therapeutics, Inc. (PTx), a commercial biotechnology company, announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to Leukine® (sargramostim), a yeast-derived recombinant human granulocyte-macrophage colony stimulating factor (rhu-GM-CSF), for the treatment of pulmonary alveolar proteinosis (PAP).

ProMIS Neurosciences, Inc. (TSX: PMN) (OTCQB: ARFXF), a biotechnology company focused on the discovery and development of antibody therapeutics targeting toxic oligomers implicated in the development of neurodegenerative diseases, issued a narrated scientific white paper titled: “The critical importance of selectivity when developing antibody therapies for Alzheimer’s disease.”

A new study shows that inhaled insulin is successful to treat Type 1 diabetes.

Guidelines focus on lifestyle and behavioral management, pharmacologic approaches, and strategies for avoiding and treating diabetes-related complications

Pioneers in reproductive medicine to recruit patients for clinical trial of new method of testing embryos for chromosome abnormalities

The University of Pittsburgh Medical Center's (UPMC) Hillman Cancer Center recently became the first cancer center in western Pennsylvania to offer immunotherapy for non-Hodgkin lymphoma cancer patients.

American Academy of Orthopaedic Surgeons issued the following announcement on Nov. 16.A new review article published in the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) finds arthroscopic (joint replacement or reconstruction) management could be a promising option for young, active patients diagnosed with GHOA.

Patients at Hunt Regional Medical Center in Greenville, Texas can now access industry leading interactive features on their patient-room televisions, thanks to the hospital’s launch this month of Allen Technologies’ E3 Patient Engagement Solution.

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to VENCLEXTA® (venetoclax tablets) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are age 75 years or older, or who have comorbidities that preclude use of intensive induction chemotherapy.

OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for OBI-888 for the treatment of Pancreatic Cancer. OBI-888 is a first in class monoclonal antibody cancer immunotherapy targeting Globo H, a glycolipid antigen.